We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+13.71%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$75.7B
AUM Growth
+$6.94B
(+10%)
Cap. Flow
-$695M
Cap. Flow
% of AUM
-0.92%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
852
New
205
Increased
261
Reduced
298
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$840M |
| 2 |
Walt Disney
DIS
|
+$492M |
| 3 |
Boeing
BA
|
+$492M |
| 4 |
Starbucks
SBUX
|
+$276M |
| 5 |
SLB Ltd
SLB
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$442M |
| 2 |
Ford
F
|
+$206M |
| 3 |
Meta Platforms (Facebook)
META
|
+$194M |
| 4 |
NVIDIA
NVDA
|
+$193M |
| 5 |
Alibaba
BABA
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.48% |
| 2 | Consumer Discretionary | 16.31% |
| 3 | Communication Services | 13.43% |
| 4 | Healthcare | 12.88% |
| 5 | Industrials | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
DexCom
DXCM
$33.1B
| $22K | ﹤0.01% |
236
-1,164
| -83% | -$104K |
|
|
CLGX
602
DELISTED
Corelogic, Inc.
CLGX
| $22K | ﹤0.01% |
+290
| New | +$21.7K |
|
603
Baxter International
BAX
$14.4B
| $21K | ﹤0.01% |
263
-23
| -8% | -$1.82K |
|
604
Fastly Inc
FSLY
$4.42B
| $20K | ﹤0.01% |
+234
| New | +$20.6K |
|
605
Invesco
IVZ
$14B
| $20K | ﹤0.01% |
+1,132
| New | +$17.4K |
|
606
Kohl's
KSS
$2.16B
| $20K | ﹤0.01% |
+497
| New | +$14.5K |
|
607
J. Jill
JILL
$279M
| $19K | ﹤0.01% |
+5,064
| New | +$19.7K |
|
608
Moderna
MRNA
$23.9B
| $19K | ﹤0.01% |
+184
| New | +$18.6K |
|
609
Olin
OLN
$2.15B
| $19K | ﹤0.01% |
+773
| New | +$15.7K |
|
610
Sabre
SABR
$835M
| $19K | ﹤0.01% |
+1,543
| New | +$14.3K |
|
|
MNDT
611
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $19K | ﹤0.01% |
+822
| New | +$12.7K |
|
612
Beyond Meat
BYND
$268M
| $18K | ﹤0.01% |
+140
| New | +$21.1K |
|
|
613
Ford
F
$55.8B
| $18K | ﹤0.01% |
2,089
-24,607,068
| -100% | -$206M |
|
614
Freeport-McMoran
FCX
$98.7B
| $18K | ﹤0.01% |
+673
| New | +$14K |
|
615
Marathon Petroleum
MPC
$90B
| $18K | ﹤0.01% |
+439
| New | +$15.8K |
|
616
Tapestry
TPR
$33.3B
| $18K | ﹤0.01% |
+583
| New | +$14.8K |
|
617
Unum
UNM
$14.5B
| $18K | ﹤0.01% |
+793
| New | +$16.4K |
|
618
Wayfair
W
$14.1B
| $18K | ﹤0.01% |
+78
| New | +$20.7K |
|
|
ETRN
619
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $18K | ﹤0.01% |
+2,230
| New | +$17.8K |
|
620
NovoCure
NVCR
$2.02B
| $17K | ﹤0.01% |
+97
| New | +$13.3K |
|
|
GAP
621
The Gap Inc
GAP
$7.74B
| $17K | ﹤0.01% |
+836
| New | +$17.6K |
|
|
WPX
622
DELISTED
WPX Energy, Inc.
WPX
| $17K | ﹤0.01% |
+2,078
| New | +$13.2K |
|
623
Principal Financial Group
PFG
$24.4B
| $16K | ﹤0.01% |
+313
| New | +$14.3K |
|
|
SAGE
624
DELISTED
Sage Therapeutics
SAGE
| $16K | ﹤0.01% |
+189
| New | +$13.9K |
|
625
Webster Financial
WBS
$12.8B
| $16K | ﹤0.01% |
+382
| New | +$13.8K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q4 2020 Portfolio in Review
As of Q4 2020, Loomis, Sayles & Company held 852 positions worth $75.7B, up 10% from $68.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Loomis, Sayles & Company's Q4 2020 filing shows 205 new, 261 increased, 298 reduced and 58 closed positions. Its largest new stake was TSMC: 1,053,323 shares worth $115M. The largest sale was Varian Medical Systems, Inc., an estimated $442M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q4 2020 buy was TSMC: 1,053,323 shares worth $115M.
- Loomis, Sayles & Company added most to Novartis in Q4 2020, an estimated $840M increase.
- Loomis, Sayles & Company's biggest Q4 2020 reduction was Varian Medical Systems, Inc., cutting an estimated $442M.
- Loomis, Sayles & Company fully exited Palomar in Q4 2020, selling an estimated $64.4M.
- Loomis, Sayles & Company's ten largest holdings make up 39% of its $75.7B portfolio in Q4 2020.
- Loomis, Sayles & Company opened 205 new positions and closed 58 in Q4 2020.
- Loomis, Sayles & Company's portfolio value rose 10% quarter-over-quarter to $75.7B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2020, filed 12 Feb 2021.